All you must know about Bacillus Calmette-Guérin or BCG vaccine

January 9, 2024 Full Body Check-up 104 Views

English

All you must know about Bacillus Calmette-Guérin or BCG vaccine

The Bacillus Calmette-Guérin or BCG vaccine is a vaccine primarily used against tuberculosis (TB). Here’s what you need to know about it:

  • Development: The BCG vaccine was developed in the early 20th century by French bacteriologists Albert Calmette and Camille Guérin. They derived it from a strain of Mycobacterium bovis, a bacterium that causes TB in cattle.
  • Purpose: This  vaccine is primarily used to prevent tuberculosis, especially in regions where TB is prevalent.
  • Effectiveness: The effectiveness of this vaccine varies widely depending on factors such as the strain of TB, age at vaccination, and geographical location. It is generally more effective against severe forms of TB in children, such as TB meningitis and miliary TB, than against pulmonary TB in adults.
  • Administration: BCG vaccine is typically administered via injection, usually into the upper arm.
  • Side Effects: Common side effects of the BCG vaccine include swelling and redness at the injection site, and sometimes a small sore or ulcer may develop. Serious side effects are rare but can include regional lymphadenitis and disseminated BCG infection, especially in immunocompromised individuals.
  • Coverage and Recommendations: These vaccination policies vary by country. In countries where TB is common, BCG vaccination is often part of the routine immunization schedule, usually given at birth or in early childhood. However, in countries with low TB incidence rates, BCG vaccination may be targeted at high-risk groups or not recommended at all.
  • Limitations: The BCG vaccine does not provide lifelong immunity against TB, and its protective efficacy wanes over time. Booster doses are not routinely recommended.
  • Research and Development: Efforts are underway to develop improved TB vaccines that offer better and longer-lasting protection than the current BCG vaccine. Several candidates are in various stages of clinical trials.

Overall, while this vaccine remains an important tool in the global fight against tuberculosis, its limitations highlight the need for continued research and investment in the development of more effective TB vaccines. ( Know more about- What is Chemotherapy? )

How is it used for bladder cancer prevention ?

The use of Bacillus Calmette-Guérin or BCG for bladder cancer prevention or treatment is a unique application of the vaccine beyond its original purpose of preventing tuberculosis. 

Here’s how BCG is utilized in the prevention of bladder cancer recurrence:

  • Intravesical Therapy: BCG is administered as a form of intravesical therapy, meaning it is instilled directly into the bladder through a catheter.
  • Treatment of Superficial Bladder Cancer: BCG therapy is primarily used in the treatment of superficial bladder cancer, particularly carcinoma in situ (CIS) and high-risk non-muscle-invasive bladder cancer (NMIBC).
  • Mechanism of Action: The exact mechanism by which BCG works against bladder cancer is not fully understood. However, it is believed that BCG stimulates the immune system, particularly the local immune response within the bladder, to recognize and attack cancer cells.
  • Induction and Maintenance Therapy: BCG treatment typically involves an initial induction phase followed by maintenance therapy. During the induction phase, BCG is usually administered weekly for six weeks. Maintenance therapy may involve additional doses of BCG given at regular intervals over a period of time, which can extend for up to three years in some cases.
  • Side Effects: BCG therapy for bladder cancer can cause side effects similar to those seen with tuberculosis vaccination, including bladder irritation, urinary frequency, urgency, and discomfort. In some cases, more severe side effects such as bladder inflammation (cystitis) or systemic infection can occur.
  • Efficacy: BCG therapy has been shown to be effective in reducing the risk of recurrence and progression of superficial bladder cancer. However, its effectiveness can vary among individuals, and not all patients respond favorably to treatment.
  • Alternative Treatments: In cases where BCG therapy is not effective or tolerated, alternative treatments such as intravesical chemotherapy or surgical interventions may be considered.

BCG therapy represents an important treatment option for patients with superficial bladder cancer, particularly those at high risk of recurrence or progression. Its ability to stimulate the immune system to target cancer cells within the bladder has made it a valuable tool in the management of this disease. ( Know more about- What is Bone Marrow Transplant ? )

How successful is BCG Vaccination ?

The success of Bacillus Calmette-Guérin or BCG vaccine varies depending on several factors including the strain of Mycobacterium tuberculosis (TB) circulating in the population, the age at vaccination, and the effectiveness of vaccination programs. 

Here’s a breakdown of BCG vaccination success:

  • Protection Against Severe Forms of TB: BCG vaccination has been shown to be highly effective in protecting against severe forms of TB, particularly TB meningitis and miliary TB, in children. These severe forms of TB can be life-threatening, especially in young children, and BCG vaccination significantly reduces the risk of their occurrence.
  • Limited Protection Against Pulmonary TB in Adults: While BCG vaccination provides some degree of protection against pulmonary TB in adults, its effectiveness in preventing this form of the disease is more variable. Factors such as the strain of TB and the prevalence of the disease in the population can influence the vaccine’s efficacy.
  • Geographical Variation: The effectiveness of BCG vaccination can vary widely depending on geographical location. In regions where TB is endemic and exposure to TB bacteria is high, BCG vaccination tends to be more effective in reducing the risk of TB infection and disease.
  • Duration of Protection: The protective effect of BCG vaccine against TB wanes over time. While it provides significant protection against severe forms of TB in childhood, its effectiveness in preventing pulmonary TB in adulthood diminishes with time.
  • Challenges and Limitations: BCG vaccination is not a perfect solution for TB prevention. It does not provide lifelong immunity against TB, and its effectiveness can be compromised by factors such as malnutrition, immunodeficiency, and variations in vaccine strain.
  • Comprehensive TB Control Strategies: BCG vaccine is just one component of comprehensive TB control strategies, which also include early diagnosis, effective treatment, infection control measures, and public health interventions.

While the BCG vaccine has proven to be highly successful in protecting against severe forms of TB in children, its effectiveness in preventing pulmonary TB in adults is more variable and tends to diminish over time. 

Despite its limitations, BCG vaccine remains an important tool in the global fight against TB, especially in regions where the disease burden is high.

What is the future of bladder cancer vaccines in cancer treatment ?

The development and future of bladder cancer vaccines and BCG vaccine holds promise in cancer treatment, offering potential alternatives or complements to existing therapies. 

Here are some aspects of the future of bladder cancer vaccines:

  • Immunotherapy Advancements: Bladder cancer vaccines are part of the broader field of cancer immunotherapy, which aims to harness the power of the immune system to target and eliminate cancer cells. Recent advancements in understanding the immune system’s role in cancer and the development of immunotherapeutic approaches have opened new avenues for bladder cancer treatment.
  • Personalized Vaccines: Researchers are exploring the development of personalized cancer vaccines tailored to individual patients based on their tumor characteristics and immune profile. These vaccines aim to stimulate the patient’s immune system to recognize and attack specific antigens present on the surface of bladder cancer cells.
  • Combination Therapies: Bladder cancer vaccines may be used in combination with other immunotherapies, such as immune checkpoint inhibitors, or conventional treatments like chemotherapy or radiation therapy. Combinatorial approaches have the potential to enhance treatment efficacy and overcome resistance mechanisms.
  • Targeting Recurrence and Metastasis: Bladder cancer vaccines are particularly promising for targeting disease recurrence and preventing metastasis. By stimulating the immune system to recognize and eliminate residual cancer cells after surgery or chemotherapy, vaccines may help reduce the risk of tumor recurrence and improve long-term outcomes for patients.
  • Clinical Trials and Research: Ongoing clinical trials and research efforts are investigating novel vaccine platforms, antigen targets, and delivery mechanisms for bladder cancer vaccines. These studies aim to optimize vaccine efficacy, minimize side effects, and identify biomarkers predictive of treatment response.
  • Challenges and Limitations: Despite the potential benefits, bladder cancer vaccines face several challenges, including tumor heterogeneity, immune evasion mechanisms, and the development of resistance. Additionally, optimizing vaccine design, delivery, and patient selection remains critical for maximizing therapeutic outcomes.
  • Patient Selection and Biomarkers: Identifying predictive biomarkers and patient selection criteria are essential for selecting appropriate candidates for bladder cancer vaccines. Biomarkers may help stratify patients based on their likelihood of responding to treatment and guide personalized therapeutic approaches.

Bladder cancer vaccines or BCG vaccine represents a promising avenue for advancing cancer treatment and improving patient outcomes. Get the best treatment for bladder cancer and full body health checkup at the best hospitals in India. 


Login to Health

Login to Health

Our team of writers is dedicated to the healthcare sector. We want our readers to have the best material to understand the health issue, learn about surgeries and procedures, consult the right doctors and finally make the right decision for their health.

Over 1 Million Users Visit Us Monthly

Join our email list to get the exclusive unpublished health content right in your inbox


    captcha